FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Preferred Pharmaceuticals Neomycin Sulfate 3 Recall

Neomycin Sulfate 3

Preferred Pharmaceuticals, Inc · Anaheim, CA

Risk level
Class II
Reported by FDA
Jul 31, 2019
Recall ID
D-1491-2019
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Neomycin Sulfate 3 starting Jul 18, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1491-2019 on Jul 31, 2019. Reason: CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility. Status: Terminated.

Why it was recalled

CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.

Product description

Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube, Generic for: Maxitrol, For External Use Only, Rx only, Mfg: Paddock Laboratories, LLC, Preferred Pharmaceuticals, Inc., The Physicians Solutions, Anaheim, CA, NDC 68788-9373-03.

Lot numbers, UPCs & expiration codes

Lot #: L2117Q, Batch: 12211717, Exp. 09/2019; F2818H, Batch: 06281808, Exp. 11/2019; B1819T, Batch: B1819T001 to B1819T048 (Inclusive), Exp. 05/2020.

Where it was sold

CA, FL

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1491-2019
Classification
Class II
Status
Terminated
Recall initiated
Jul 18, 2019
FDA report date
Jul 31, 2019
Quantity
171 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc

Original FDA data

Every field from FDA enforcement report D-1491-2019, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Terminated
Country
United States
Event ID
83370
Address
1250 N Lakeview Ave Ste O
Code information
Lot #: L2117Q, Batch: 12211717, Exp. 09/2019; F2818H, Batch: 06281808, Exp. 11/2019; B1819T, Batch: B1819T001 to B1819T048 (Inclusive), Exp. 05/2020.
Postal code
92807-1801
Report date
Jul 31, 2019
Product type
Drugs
Recall number
D-1491-2019
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc
Product quantity
171 tubes
Termination date
Apr 24, 2023
Reason for recall
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube, Generic for: Maxitrol, For External Use Only, Rx only, Mfg: Paddock Laboratories, LLC, Preferred Pharmaceuticals, Inc., The Physicians Solutions, Anaheim, CA, NDC 68788-9373-03.
Distribution pattern
CA, FL
Recall initiation date
Jul 18, 2019
Initial firm notification
E-Mail
Center classification date
Jul 22, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1491-2019, published Jul 31, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls